Coronavirus describes a family of infectious infections that can lead to a run of mellow to serious respiratory infections. These infections can transform quickly and frame new sorts of the disease, including serious acute respiratory disorder coronavirus 2 (SARS-CoV-2) recognized in China in 2019, that is responsible for the widespread of COVID-19 illness. Even though SARS was viably put under containment, arrangements of China and many other nations were inadequate for the plague regarding the late announcing to wellbeing authorities, not enough quarantine and confinement gauges, destitute cleanliness safeguards, and powerlessness of health care specialists. This review outlines and compares the major control measures actualized in China to those in the United States and highlights particular highlights of the Chinese approach. The lessons may offer assistance to policy creators to adjust outbreak management procedures for better readiness and initial reaction in the future.
Epidemic reaction capacity
China’s leadership has strengthened and advanced its epidemic response to future events. Comparing the responses to the development of SARS and COVID 19, the results are unmistakable. The Wu and McGoogan studies appear to be the timeline for the most pressing opportunities for SARS and COVID 19 illnesses. They said they were late in notifying WHO about 300 SARS episodes and had already had 5 demises in comparison to 27 and 0 deaths with COVID 19. The main official statement of COVID 19 first case took place on the 31st of December 2019, when the WHO China National Office was notified that nearly a group of 27 outbreaks of pneumonia of unidentified aetiology were detected in Wuhan, Hubei Province, China. (AlTakarli 2020). The time to distinguish SARS infections was two months compared to one week for COVID 19, so the country made great efforts to enhance the capacity of the research facility.
In part, Chinese researchers have assembled a gigantic information outline that bestows the finest accessible image of the sickness. The signs of progress in symptomatic viral strategies, the bioinformatics capabilities to assess the information, and the rate at which genome sequencing and information were gotten were exceptionally accommodating in creating symptomatic units and putting up quick preparatory gauges. As for the United States, little advancements have been made towards formulating responses to the technology. Researchers and scientists in the U.S, however, have successfully discovered various vaccines which have been used in preventing the spread of the virus.
Large scale monitoring and case identification
In infected patients, WHO China and CDC China provided clinically recognizable evidence that there are clear criteria for distinguishing cases under relapse testing. Since then, experts across the country have published follow-ups on health techniques and outbreaks and contacts, allowing approximately 2000 groups of epidemiologists to come in contact with many others daily in Wuhan (Burki2020). Additionally, screening of temperature done in the wide-community has been updated by “installing infrared thermometers in flight terminals, sites, long-distance transportation sites, and ship terminals.”
The Chinese government has contributed to a new and highly innovative framework. One is a mobile application that uses health code color frame. It divides people into three color factions based on the status of their health and their travel history. It then decides whether to separate them. Another degree that has made a difference in disease monitoring and management is a street surveillance system that captures pedestrians not wearing a mask and distinguish the side effects that occur. This system is viable because it was already used during the SARS flare-up but, as of late, overhauled to incorporate facial acknowledgment and to cover all ranges in China. The Unites states never implemented most of these tracking advancements. What has been used is the contact tracing whereby individuals infected were required to identify everyone they contacted. This system is ineffective as compared to China’s facial identification technology.
Social distancing and lockdown
After the Coronavirus was declared a world pandemic, various countries implemented measures to curb the spread of the infection. China, which was the initial country to experience the epidemic, however, had already devised and implemented most of these ways. From partial to total city lockdown, the country ensured no public gatherings whatsoever for the better part of 2020. The lockdown measures meant no business was open, and people had to stock food supplies in their homes periodically. Additionally, when the lockdowns were lifted, people had to observe physical distancing strictly. In the United States, on the other hand, no major lockdowns were implemented in any of the states. There were partial lockdowns which were not enough to control the spread of the disease. Additionally
Healthcare facilities preparedness
As a response measure to the pandemic, the Chinese government ensured that all hospitals and healthcare facilities were equipped to handle Covid-19 patients. This led to the contribution of numerous additional healthcare facilities within a short period. These healthcare facilities were also equipped with modern ventilators and respirators. Additionally, more health care professionals were trained to handle Covid-19 patients. As for the United States, the situation was a bit contrasting. Little preparations were made to accommodate the rising number of Covid-19 patients. Even though there was some advancement in equipping hospitals, this was not enough to help curb the spread of the virus.
Conclusion
Preparing for epidemics requires the intervention of both the government and the public. Covid-19 is a respiratory virus infection that came around in 2019 and quickly spread worldwide. Depending on the country’s preparedness, the pandemic can either spread or be controlled. China was among the first countries to experience the effects of the virus. Additionally, compared to other countries like the United States, it was also the first to contain the disease effectively.
Reference
AlTakarli, N. S. (2020). China’s response to the COVID-19 outbreak: A model for epidemic preparedness and management. Dubai Medical Journal, 3(2), 44-49.
Burki, T. (2020). China’s successful control of COVID-19. The Lancet Infectious Diseases, 20(11), 1240-1241.